Results 181 to 190 of about 52,240,321 (193)
Drugs previously repurposed to target blood cancers reduced neuroblastoma and glioblastoma cell growth and viability. However, their levels of anticancer activity were different and their clinical application may be problematic due to side effects at effective doses.
Abhishek Kharawatkar +4 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Metabolomics in cancer research and emerging applications in clinical oncology
Ca-A Cancer Journal for Clinicians, 2021David Kirsch +2 more
exaly
Blueprint for cancer research: Critical gaps and opportunities
Ca-A Cancer Journal for Clinicians, 2021exaly

